SLIDE 1
Prudent use of antimicrobials in animals
CVO meeting, EE Presidency – Brussels 25 October 2017 Paola Colombo
Prudent use of antimicrobials in animals CVO meeting, EE Presidency - - PowerPoint PPT Presentation
Prudent use of antimicrobials in animals CVO meeting, EE Presidency - - PowerPoint PPT Presentation
Prudent use of antimicrobials in animals CVO meeting, EE Presidency Brussels 25 October 2017 Paola Colombo Introduction Antimicrobial resistance Monitoring Audit One Health Support Prudent use Fact finding Introduction
SLIDE 2
SLIDE 3
Prudent use Fact finding Monitoring Audit One Health Support
Antimicrobial resistance
SLIDE 4
Introduction
Questionnaire (all MSs and EEA countries and stakeholders, September 2015) Fact-finding missions:
- 2016: 9 (DK, SI, DE, FI, CZ, NL, ES, CY, RO)
- 2017: 4 (NO, FR, LV, SE)
- 2018: 4 planned
Interim overview report (2017) Overview report (2018)
SLIDE 5
Introduction
SLIDE 6
Role of veterinarians
- Gatekeepers in the
distribution and use of AM and animal health experts
- From "firefighters"
to Advisors => Contract
- Potential conflict of
interest (sale and prescribing of veterinary medicinal products)
SLIDE 7
Raising awareness
- All countries increased level of
awareness
- Avoiding duplication of effort
(use of available information)
- Training for vets
(up-to-date with developments, eg CIA)
SLIDE 8
Prevention is better than cure
SLIDE 9
Prevention strategies
Good practice
- Use of vaccines
- Enhanced management
- Hygiene practices
- Novel Feed additives
SLIDE 10
Challenges
- Support to farmers
- Potential restriction (zinc oxide)
- Availability of vaccines, costs
and practicality issues
Prevention strategies
SLIDE 11
As little as possible, as much as necessary Prudent Use of Antimicrobials
- Treatment guidelines (1st, 2nd,
3rd choice AM to avoid routine use
- f CIAs)
- Susceptibility/diagnostic
tests (often mandatory for CIAs to show no suitable alternatives exist) => map regional trends (Résapath)
- Benchmarking =>comparing
quantity of AM in same farming sector and thresholds => max use
- f AM at each stage of production.
(sufficient flexibility to avoid AW issues required)
SLIDE 12
Restrictions on use
- Specific restrictions on use of CIAs => e.g.
susceptibility /diagnostic tests; bans on prophylactic and metaphylactic use etc.
- Updated advice on colistin =>withdrawal of
VMPs and voluntary initiatives
- Off-label use (dosage above SPC)=> different
approaches
- New Medicated Feed Regulation
potential ban on preventive use
- New VMP Regulation
prophylaxis and metaphylaxis being discussed
SLIDE 13
Does it work? And What does work?
- MS with previously very high use of
antimicrobials noted a decrease of 58%
- Voluntary initiatives => in the
absence of regulations changes should be driven by the veterinarians and farming stakeholders
- Benchmarking of thresholds
schemes (policies, penalties)
SLIDE 14
One Health approach
- Good cooperation between vet and
human health sectors (or blame game?)
- MS priority to develop and implement
One Health national AMR action plans
- Alarming AMR data and levels of
Abs use in some MS in both animals and humans
- Reduce AM use without jeopardising
AHAW, farm productivity, profitability?
- Impact of vet prudent use activities
seen in some AMR monitoring data ?
SLIDE 15